Opportunities and challenges in the immunological therapy of pediatric malignancy: a concise snapshot
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Link
http://link.springer.com/article/10.1007/s00431-017-2982-0/fulltext.html
Reference80 articles.
1. Ahmed N, Brawley VS, Hegde M, Robertson C, Ghazi A, Gerken C, Liu E et al (2015) Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor-modified T cells for the immunotherapy of HER2-positive sarcoma. J Clin Oncol Off J Am Soc Clin Oncol 33:1688–1696
2. Ansell SM (2017) Nivolumab in the treatment of Hodgkin lymphoma. Clin Cancer Res 23:1623–1626
3. Armenian SH, Kremer LC, Sklar C (2015) Approaches to reduce the long-term burden of treatment-related complications in survivors of childhood cancer. Am Soc Clin Oncol Educ Book 35:196–204. doi: 10.14694/EdBook_AM.2015.35.196
4. Armstrong GT, Pan Z, Ness KK, Srivastava D, Robison LL (2010) Temporal trends in cause-specific late mortality among 5-year survivors of childhood cancer. J Clin Oncol 28:1224–1231
5. Armstrong GT, Chen Y, Yasui Y, Leisenring W, Gibson TM, Mertens AC, Stovall M, Oeffinger KC, Bhatia S, Krull KR, Nathan PC, Neglia JP, Green DM, Hudson MM, Robison LL (2016) Reduction in late mortality among 5-year survivors of childhood cancer. N Engl J Med 374(9):833–842. doi: 10.1056/NEJMoa1510795
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immune checkpoint inhibitors therapy as the game-changing approach for pediatric lymphoma: A brief landscape;Critical Reviews in Oncology/Hematology;2024-01
2. The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity;Frontiers in Immunology;2021-06-10
3. Controversies on the possible role of immune checkpoint inhibitors in pediatric cancers: balancing irAEs and efficacy;Tumori Journal;2021-04-20
4. Single daily dosing versus divided dosing intravenous ondansetron to prevent chemotherapy‐induced nausea and vomiting among children: A comparative randomized double‐blind controlled trial;Pediatric Blood & Cancer;2021-03-23
5. Cancer and antineoplastic therapies and the risk of infection in the pediatric cancer patient;Pediatric Transplant and Oncology Infectious Diseases;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3